
Membership was introduced solely to assist authors in avoiding article processing fees
Read MoreReviewers on our fully open access journals receive a 20% discount on OA charges
Read MoreReviewers are the backbone of the publishing process. Peer review ensures that
Read MoreThe Award will be given annually to the top three papers for three different subject areas.
Read MoreUR Forum Open access journals do not charge readers for access. As a result, price barriers are reduced or eliminated entirely.
Read MoreScientific research shows that publishing in open access results in more citations.
Read MoreAuthors with published works in our journals are eligible to present their work at relevant conferences.
Read MoreAuthors who publish their work in open access journals will have more opportunities
Read MoreThe Journal of Diabetes, Endocrinology, and Metabolic Disorders (JDEMD) is a peer-reviewed, open-access journal dedicated to advancing research in diabetes, endocrinology, and metabolic diseases. Our mission is to provide a platform for high-quality research that addresses the challenges of understanding, diagnosing, and treating these complex conditions.
We publish original research, reviews, clinical studies, and expert opinions on a wide range of topics, including diabetes management, endocrine disorders, metabolic syndrome, obesity, insulin resistance, thyroid disorders, hormonal imbalances, and innovative therapies. We also focus on emerging technologies, personalized medicine, and regenerative treatments.
Our journal fosters collaboration between researchers, clinicians, and healthcare professionals, aiming to bridge the gap between scientific discoveries and clinical practice. By offering open access, we ensure the rapid dissemination of valuable knowledge, ultimately improving patient care, advancing treatment options, and promoting global health in the fields of diabetes, endocrinology, and metabolic health.
Frequency of Publication: Quarterly
Language of Publication: English
Format of the Publication: Online
Establishment of the Journal: 2025
Diabetes
Endocrinology
Metabolic Disorders
Type 1 and Type 2 Diabetes
Insulin resistance
Glucose metabolism
Glycemic control
Diabetes management
Hyperglycemia
Diabetic complications
Insulin therapy
Continuous glucose monitoring
Diabetic neuropathy
Diabetic retinopathy
Beta-cell dysfunction
Glucagon-like peptide-1 (GLP-1)
Insulin secretion
Hormonal regulation
Thyroid disorders
Hypothyroidism
Hyperthyroidism
Pituitary disorders
Adrenal insufficiency
Endocrine glands
Cortisol imbalance
Polycystic ovary syndrome (PCOS)
Reproductive hormones
Growth hormone deficiency
Testosterone deficiency
Endocrine disruptors
Endocrine disruptors
Calcium and bone metabolism
Dyslipidemia
Insulin resistance syndrome
Non-alcoholic fatty liver disease (NAFLD)
Atherosclerosis
Hyperlipidemia
Leptin resistance
Hyperinsulinemia
Mitochondrial dysfunction
Fatty acid metabolism
Lipotoxicity
Inflammation and metabolism
Metabolic adaptation
Metabolic adaptation
Cardiometabolic risk
Gut microbiota and metabolism
Insulin sensitivity
Metabolic health
Genetic predisposition
Hormone replacement therapy
Clinical trials
drug metabolism
metabolic syndrome
clinical endocrinology
pharmacokinetics
bone metabolism
preclinical pharmacology
diabetic
metabolic disease
endocrine dysfunction
meta-analyses
endocrine disease
diabetology
clinical medicine
drug tolerability
endocrine disease
exercise
obesity
drug safety
endocrine tumors
metabolism
obese
therapeutics
genetics
interventions
hormones
hormone therapy
diet
dietary
therapies
oncology
pediatrics and Nanatology
thyroid
adrenal
pituitary
parathyroid
testis
ovary
estrogen
testosterone
corticosteroids
growth hormone
prolactin
vitamin D
bone and mineral
osteoporosis
clinical pharmacology
experimental pharmacology
lipid metabolism